Novo Nordisk | Passivo Circulante

Current Liabilities Alterar Data
ANI Pharmaceuticals USD 136.89M 8.59M 2024-03
Aurora Cannabis CAD 107.38M 10.6M 2023-12
Bausch Health Companies USD 4.4B 103M 2024-03
Bristol-Myers Squibb USD 25.82B 2.36B 2024-03
Canopy Growth CAD 234.72M 13.37M 2024-03
Catalent USD 1.01B 29M 2024-03
Corcept Therapeutics USD 97.2M 7.3M 2024-03
Drreddys Laboratories INR 93.6B 9.42B 2023-12
Eli Lilly USD 18.6B 3.4B 2024-03
GlaxoSmithKline GBP 19.85B 1.22B 2024-03
Merck USD 25.1B 2.01B 2024-03
Novartis USD 29.29B 2.9B 2024-03
Novo Nordisk DKK 165.61B 4.05B 2024-03
Pacira USD 93.44M 3.94M 2024-03
Perrigo USD 1.55B 31.8M 2024-03
Prestige Brands USD 117.05M 10.39M 2024-03
Supernus Pharmaceuticals USD 314.55M 24.36M 2024-03
Zoetis USD 1.91B 20M 2024-03



Novo Nordisk Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.